Stay updated on Risankizumab in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.

Latest updates to the Risankizumab in Ulcerative Colitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s interface revision was updated from one ClinicalTrials.gov release to the next (v3.5.2 → v3.5.3), reflecting a site/version update rather than any change to the underlying trial history or record details.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision v3.5.2 was added and v3.5.0 was removed from the history.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2; this appears to be a software version update with no visible changes to content or layout.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page history shows an addition of Revision: v3.4.2 and deletion of Revision: v3.4.1. This is metadata about versioning and does not modify study data or user-visible content.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed from the history.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.